Conversion surgical after neoadjuvant immunochemotherapy achieves survival comparable to initially resectable disease in borderline resectable esophageal cancer
- DOI
- 10.1007/s10147-026-03018-x
- Published
- 2026-03-28
- Container
- International Journal of Clinical Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10147-026-03018-x,
title = {Conversion surgical after neoadjuvant immunochemotherapy achieves survival comparable to initially resectable disease in borderline resectable esophageal cancer},
author = {Binwen Xu and Hanxiao Wang and Chengcheng Zhang and Tao Luo and Jie Xiong and Xingqiang Ran and Junhong Liu and Guidong Shi and Maoyong Fu},
year = {2026},
journal = {International Journal of Clinical Oncology},
doi = {10.1007/s10147-026-03018-x},
url = {https://doi.org/10.1007/s10147-026-03018-x}
}RIS
TY - JOUR TI - Conversion surgical after neoadjuvant immunochemotherapy achieves survival comparable to initially resectable disease in borderline resectable esophageal cancer AU - Binwen Xu AU - Hanxiao Wang AU - Chengcheng Zhang AU - Tao Luo AU - Jie Xiong AU - Xingqiang Ran AU - Junhong Liu AU - Guidong Shi AU - Maoyong Fu PY - 2026 JO - International Journal of Clinical Oncology DO - 10.1007/s10147-026-03018-x UR - https://doi.org/10.1007/s10147-026-03018-x ER -
APA
Xu, B., Wang, H., Zhang, C., Luo, T., Xiong, J., Ran, X., Liu, J., Shi, G., & Fu, M. (2026). Conversion surgical after neoadjuvant immunochemotherapy achieves survival comparable to initially resectable disease in borderline resectable esophageal cancer. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-026-03018-x
Source records
- crossref · retrieved 2026-09-27T10:13:10.207Z